Indication
Chronic hepatitis C - genotype 5
Chronic hepatitis C - genotype 5 is a persistent, bloodborne viral infection of the liver caused by the hepatitis C virus (HCV) classified specifically within genetic clade 5 (predominantly subtype 5a). Read more about Chronic hepatitis C - genotype 5
6 drugs 3 manufacturers
Drugs that treat it
Common Chronic hepatitis C - genotype 5 therapies.
EPCLUSA (sofosbuvir/velpatasvir)
VOSEVI (sofosbuvir/velpatasvir/voxilaprevir)
MAVYRET (glecaprevir/pibrentasvir)
LEDIPASVIR-SOFOSBUVIR (ledipasvir/sofosbuvir)
SOFOSBUVIR-VELPATASVIR (sofosbuvir/velpatasvir)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonChronic hepatitis C - genotype 5 is a persistent, bloodborne viral infection of the liver caused by the hepatitis C virus (HCV) classified specifically within genetic clade 5 (predominantly subtype 5a).
While clinically uncommon globally, it is notably endemic in regions of southern Africa and observed in specific focal clusters in parts of Europe.
Pathophysiologically, the virus replicates within hepatocytes, evading the host immune response and driving chronic hepatic inflammation.
Although often clinically silent or mildly symptomatic in early stages, chronic infection leads to progressive fibrosis, cirrhosis, hepatic decompensation, and hepatocellular carcinoma over decades.
Identifying genotype 5 via molecular testing is clinically critical to guide the selection and duration of antiviral therapies with appropriate pan-genotypic or genotype-specific regimens.
- nih.gov
Chronic hepatitis C - genotype 5 is a persistent, bloodborne viral infection of the liver caused by the hepatitis C virus (HCV) classified specifically within genetic clade 5 (predominantly subtype 5a) While clinically uncommon globally, it is notably endemic in regions of southern Africa and observed in specific focal clusters in parts of Europe
- nih.gov
Chronic hepatitis C - genotype 5 is a persistent, bloodborne viral infection of the liver caused by the hepatitis C virus (HCV) classified specifically within genetic clade 5 (predominantly subtype 5a)
- who.int
Chronic hepatitis C - genotype 5 is a persistent, bloodborne viral infection of the liver caused by the hepatitis C virus (HCV) classified specifically within genetic clade 5 (predominantly subtype 5a) Pathophysiologically, the virus replicates within hepatocytes, evading the host immune response and driving chronic hepatic inflammation
- healthcentral.com
Pathophysiologically, the virus replicates within hepatocytes, evading the host immune response and driving chronic hepatic inflammation Identifying genotype 5 via molecular testing is clinically critical to guide the selection and duration of antiviral therapies with appropriate pan-genotypic or genotype-specific regimens
- cdc.gov
Although often clinically silent or mildly symptomatic in early stages, chronic infection leads to progressive fibrosis, cirrhosis, hepatic decompensation, and hepatocellular carcinoma over decades
- nih.gov
Although often clinically silent or mildly symptomatic in early stages, chronic infection leads to progressive fibrosis, cirrhosis, hepatic decompensation, and hepatocellular carcinoma over decades
- va.gov
Identifying genotype 5 via molecular testing is clinically critical to guide the selection and duration of antiviral therapies with appropriate pan-genotypic or genotype-specific regimens
Personalize your experience
Follow Chronic hepatitis C - genotype 5 and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.